Literature DB >> 3285914

A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.

E Kurrle1, G Ehninger, M Freund, G Heil, D Hoelzer, H Link, P S Mitrou, S Ohl, W Queisser, G Schlimok.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285914     DOI: 10.1007/bf00320111

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


× No keyword cloud information.
  20 in total

Review 1.  Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.

Authors:  R L Capizzi; B L Powell; M R Cooper; J J Stuart; H B Muss; F Richards; D V Jackson; D R White; C L Spurr; P J Zekan
Journal:  Semin Oncol       Date:  1985-06       Impact factor: 4.929

2.  Intensive chemotherapy for acute myelogenous leukemia.

Authors:  R P Gale; K A Foon; M J Cline; J Zighelboim
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

3.  Rapid remission induction in adult acute non-lymphoblastic leukaemia.

Authors:  D Dubovsky; L Kernoff; P Jacobs
Journal:  Eur J Cancer       Date:  1978-11       Impact factor: 9.162

4.  Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.

Authors:  J Yates; O Glidewell; P Wiernik; M R Cooper; D Steinberg; H Dosik; R Levy; C Hoagland; P Henry; A Gottlieb; C Cornell; J Berenberg; J L Hutchison; P Raich; N Nissen; R R Ellison; R Frelick; G W James; G Falkson; R T Silver; F Haurani; M Green; E Henderson; L Leone; J F Holland
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

5.  Age adapted induction and intensified consolidation therapy in acute myelogenous leukemia.

Authors:  E Kurrle; G Ehninger; M Freund; G Heil; D Hoelzer; H Link; P S Mitrou
Journal:  Onkologie       Date:  1986-06

6.  Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.

Authors:  A M Yeager; H Kaizer; G W Santos; R Saral; O M Colvin; R K Stuart; H G Braine; P J Burke; R F Ambinder; W H Burns
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

Review 7.  Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.

Authors:  R Champlin; R P Gale
Journal:  Semin Hematol       Date:  1987-01       Impact factor: 3.851

8.  High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.

Authors:  S N Wolff; R H Herzig; G L Phillips; H M Lazarus; J P Greer; R S Stein; W A Ray; G P Herzig
Journal:  Semin Oncol       Date:  1987-06       Impact factor: 4.929

9.  High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia.

Authors:  W Hiddemann; H Kreutzmann; K Straif; W D Ludwig; R Mertelsmann; R Donhuijsen-Ant; E Lengfelder; Z Arlin; T Büchner
Journal:  Blood       Date:  1987-03       Impact factor: 22.113

10.  High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study.

Authors:  S N Wolff; J Marion; R S Stein; J M Flexner; H M Lazarus; T R Spitzer; G L Phillips; R H Herzig; G P Herzig
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.